Scipio Bioscience

About:

A Paris-based biotechnology company .

Twitter/X: Scipiobio

Top Investors: Verve Ventures, HTGF | High-Tech Gruenderfonds, European Innovation Council, Seventure Partners, M Ventures

Description:

Scipio Bioscience, a Paris-based biotechnology company, provides a novel sample preparation solutionfor single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics.

Total Funding Amount:

$17M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2017-01-01

Founders:

Pierre Walrafen, Stuart Edelstein

Number of Employees:

11-50

Last Funding Date:

2023-07-28

IPO Status:

Private

Industries: